Impact of a MVM to Support Biomarkers Associated With Conception and Pregnancy in Healthy Women.
Impact of a MVM to Support Biomarkers Associated With Conception and Pregnancy in Healthy Women.
NCT ID: NCT06505408 Phase: NA Status: COMPLETED Enrollment: 60 Completion: 2025-01-20
Conditions
Healthy Adult Women of Child Bearing Age
Interventions
Multivitamin, Placebo
Summary
The goal of this clinical trial is to investigate the effects multivitamin (MVM) on blood biomarkers that are associated with healthy pregnancy and conception in adult women. The main question it aims to answer is:
Is there a significant change in blood biomarkers from baseline (week 0) to end of intervention (week 12) in healthy women consuming multivitamin compared to participants consuming the placebo product?
Participants will:
Take drug MVM or a placebo every day for 12 weeks Visit the clinic at baseline and 12 weeks for serum blood draws and measurements Complete a series of surveys at baseline and 12 weeks
Primary Outcome
Change from baseline (week 0) to end of intervention (week 12) on Serum Folate